Global Reach. Technical Precision.
Intellectual property is a global asset. TAEUS operates internationally to provide seamless, high-level patent evaluation, reverse engineering, and litigation support across borders.
We place our engineering and legal strategy teams in key global tech hubs to ensure we can respond to complex, cross-border IP disputes and licensing campaigns.

TAEUS Corporation
Corporate Headquarters and North American Sales Office
4308 Ridgelane Drive
Colorado Springs, CO 80918tel. +1 719 325 5000


TAEUS Japan KK
Japan Sales Office
310 Sengokuyama ANNEX,
5-3-20, Toranomon, Minato-Ku, Tokyo 105-0001 Japantel. (Japan) +81 80 4054 6543
tel. (USA) +1 415 992 7389

TAEUS Asia Pacific Sdn. Bhd.
Asia Pacific Sales Office
Level 32, Menara Prestige
No. 1, Jalan Pinang
50450 Kuala Lumpur, Malaysia

TAEUS LATAM
Latin America Sales Office
Cra 11 #79-66 Edificio 80 eleven
Bogota, Colombiatel. (Colombia) +601 653 3110
tel. (USA) +1 719 445 1057

TAEUS Continental, Ltd.
Europe Sales Office
Lee View House
13 South Cork Terrace
Cork, Irelandtel. (Belgium) +32.491.366345
tel. (USA) +1.719.325.5000
Expanding Our Footprint in Asia
To better serve our clients in the rapidly growing Asian technology and manufacturing markets, TAEUS is proud to announce our upcoming strategic hub in Thailand. Opening late this year, this expansion will provide localized, on-the-ground support for reverse engineering, patent monetization, and IP evaluation across the entire APAC region.
Work With Us Anywhere
No matter where your enterprise is headquartered, our team is equipped to protect and monetize your intellectual property.
Breakthrough Opioid Use Disorder (OUD) Asset Sale
Final LOI Due TAEUS is managing the complete 100% asset divestiture of the Computerized Oral Prescription Administration System (COPA™) on behalf of Berkshire Biomedical Corporation. Designed to revolutionize treatment in sensitive areas like Opioid Use Disorder (OUD) and controlled drug administration, COPA™ represents a turnkey opportunity to acquire a fully validated, highly secure digital health…
Read More about Breakthrough Opioid Use Disorder (OUD) Asset SaleIntellectual Capital Financing
The most valuable asset of any corporation is its Intellectual Capital (IC). Unfortunately, no banks, the US Small Business Administration (SBA), or other institutions in the United States will allow IC as collateral for loans. Fortunately, that is not the case in Europe and other places around the world. IC, properly defined, includes not only…
Read More about Intellectual Capital FinancingTAEUS & Microsoft Beget PatentBooks
TAEUS has had a long and colorful history with Microsoft. For nearly four decades, beginning in the early 1990s, TAEUS has investigated Microsoft for patent infringement. In fact, the TAEUS history with Microsoft was PatentBooks genesis. Unisys, via its Burroughs acquisition, developed the Lempel, Ziv, Welch (LZW) patented technology to deal with submarine sonar reports.…
Read More about TAEUS & Microsoft Beget PatentBooksUnlocking IP Potential: Satellite Forensics, Disaster Relief IP, & Software Litigation
Hello from beautiful Colorado Springs, Colorado! As we near the end of summer, we hope you are enjoying fond memories of relaxing vacations and time spent outdoors with your loved ones. TAEUS has had a busy several months. We’ve compiled a selection of our recent and ongoing projects into this new edition of the TAEUS…
Read More about Unlocking IP Potential: Satellite Forensics, Disaster Relief IP, & Software LitigationWhere We’ve Been and Where We’re Going
TAEUS Corporation is the world’s first engineering company dedicated to patent licensing, formed originally in July 1992. TAEUS grew organically, helping AT&T identify the best patents obtained in its 1992 NCR purchase. TAEUS served not only AT&T, but all its daughter companies, including Lucent, Avaya, and LSI, for the next two decades. In 1994, TAEUS…
Read More about Where We’ve Been and Where We’re GoingGlobal Footprint
TAEUS opened TAEUS Europe, Ltd., its first international subsidiary, in 1996 in London, investigating Microsoft for antitrust on behalf of the European Commission, illustrating how the instructions Microsoft provided to users did not reflect how the Windows® operating system and Internet Explorer® actually worked. The European Commission’s €9M contract with TAEUS Europe, Ltd. yielded a…
Read More about Global FootprintCOVID-19 Effects on TAEUS
The entire world, including TAEUS, was affected by the onset of COVID-19 in various ways that differ from one company to another. Many companies had to adapt to working remotely. TAEUS has been working remotely as a specialized team since its founding in 1992! This advantage allowed TAEUS to continue working while other companies had…
Read More about COVID-19 Effects on TAEUSMarket Changes
Many patent owners resort to patent brokerage services because they either don’t utilize their patents, or they lack the financial resources to litigate. TAEUS Corporation has helped patent owners monetize their patents since 1992. The patent sale market has gone dry recently. In 2020, the actual patent sales by market year of sale dropped to…
Read More about Market ChangesTAEUS War Stories: EC vs. Microsoft
Some years ago, TAEUS Europe Ltd. won a €9 million European Commission (EC) competitive tender for assistance with their antitrust investigation of Microsoft. The EC was responding to complaints from Microsoft competitors that believed that Microsoft was blocking them from making products compatible with its Internet Explorer™ internet browser and Microsoft Windows™ operating system. …
Read More about TAEUS War Stories: EC vs. MicrosoftRevolutionizing Patent Licensing
Since the very first patent was issued in the 14th century, intellectual property and intellectual property protection practices are still very relevant in today’s world, despite significant changes. New inventions and innovations are critical to societal progress, for without them, society would become stagnant and forward progression would cease. TAEUS is committed to adapting to…
Read More about Revolutionizing Patent Licensing





